Liraglutide, glucagon-like peptide-1(GLP-1) receptor agonist
Be the first to review this product! Submit a review
|
(0 Publication)
Liraglutide (ab231359) is a glucagon-like peptide-1 (GLP-1) receptor agonist. Molecular weight (MW): 3751; Purity > 99%.
View Alternative Names
GLP-1 receptor, GLP1R_HUMAN, Glucagon-like peptide 1 receptor, MGC138331, OTTHUMP00000016340
- Chemical Structure
Lab
Chemical Structure - Liraglutide, glucagon-like peptide-1(GLP-1) receptor agonist (AB231359)
2D chemical structure image of ab231359, Liraglutide, glucagon-like peptide-1(GLP-1) receptor agonist
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GLP-1R serves as an important player in the regulation of insulin secretion. It is not part of a complex but acts as a standalone receptor. When GLP-1 binds to GLP-1R it triggers the activation of adenylyl cyclase increasing cyclic AMP levels and facilitating insulin secretion. This process is glucose-dependent meaning that it enhances insulin release only when blood glucose levels are elevated therefore preventing hypoglycemia.
Pathways
GLP-1R is an integral component of the incretin signaling pathway and the insulin signaling pathway. Through these pathways it influences key metabolic processes. Incretin hormones like GLP-1 improve glucose-dependent insulin secretion involving proteins such as GLP-1R and other incretin-related receptors. Additionally GLP-1R interacts with insulin receptor pathways to modulate glucose uptake in tissues.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com